PRECISION PHAGE THERAPY

Vésale Bioscience

Nature’s remedy for tackling superbugs and antimicrobial resistance

Our mission

Vésale Bioscience

Stem from our advanced R&D on bacteriophages, our Mission is to develop robust modern solutions to fight antimicrobial-resistant infections.

Antimicrobial resistance (AMR) are a substantial public health issue. From around 1.3 million deaths a year today, the AMR burden is expected to reach ten million/y deaths by 2050, more than cancer.

Our approach is to work on personalized, selective, and specific phage therapies against those multi-resistant bacterial infections.

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

INTERESTED IN SOLVING THE PROBLEM OF ANTIMICROBIAL RESISTANCE (AMR)

Know more

Vésale Bioscience in the press

They talk about us.

L’Écho

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

La Libre

Vésale Bioscience enters into an innovative and ambitious collaboration with the Belgian Army

Lpost

Important reinforcement for Vésale Bioscience: the managers of Vésale Bioscience have hired Guillaume de Viron as Chief Financial Officer (CFO) of the research and development (R&D) company